Life Science Network

A fabulous, complimentary life science networking reception is coming up during Advances in Single Cell & Spatial Biology on 9/14. CG Life is co-hosting. It should make for an excellent evening of drinks, bites, and science! buff.ly/3LdiP0d

Roche buys U.S. rights to Roivant bowel disease drug in $7.1 billion deal buff.ly/3Ft8vxH

New Cancer Therapy Target Stops Tumor Cells From Sharing Resources buff.ly/3tCcmWK

Oncolytic Virus Improves Survival in Glioblastoma Trial buff.ly/45BGyyn via @GENbio

Seed-stage Bay Area biotechs kick off return of BIO Investor Forum - San Francisco Business Times buff.ly/3M8fMGS via @SFBusinessTimes

Carl Icahn sues Illumina board members over Grail acquisition - buff.ly/3M7viTk

Flipped coins found not to be as fair as thought buff.ly/3tzxYmw via @physorg_com

Aldeyra braces for potential dry eye disease rejection after FDA says more data are necessary - buff.ly/3M7323n

These Japanese life science firms came to San Diego to study startups buff.ly/3S3eP6t

Better Therapeutics begins rolling out digital app for Type 2 diabetes buff.ly/3ZYlsJi

Pfizer Expands in Immunology With FDA Approval of New Ulcerative Colitis Drug buff.ly/3FkOLMQ

Thermo Fisher Scientific to buy Olink in $3.1 billion deal reuters.com/markets/deals/…

Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup - buff.ly/3trFVtR

A decade later, biotech’s CRISPR revolution is still going strong. I traced the history of gene editing startups and what it means for the future. The result? A deep dive into the schools and scientists who mold the future of medicine. For @BioPharmaDive biopharmadive.com/news/crispr-bi…

Chemogenetics Can Dampen Pain Responses in Lab Tests buff.ly/3tp55t9 via @clinicalomics

Cell Therapy for Drug-Resistant Epilepsy a Preclinical Success buff.ly/46FyPA6 via @GENbio

Twist Bioscience, Bayer Enter Antibody Discovery Deal Valued at up to $188 Million buff.ly/3LJR6Ve via @clinicalomics

Researchers are using CRISPR for more complex diseases such as Alzheimer's. Studies done at @UCSanDiego, @DukeU, and more are using CRISPR to target genes found in properties responsible for the disease. Read more from @DrewQJoseph at @statnews: bit.ly/44LOmxw

Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone $ETON buff.ly/45xS1zb via $ETON

BridgeBio and Resilience Form Gene Therapy Partnership buff.ly/3Qd3ZtD via @GENbio

Gilead stops another CD47 study, this time in acute myeloid leukemia - buff.ly/46riCPc